News & Media

Bladder cancer biotech Viventia Bio files for an $86 million IPO

The Winnipeg, Canada-based company, which was founded in 1995, plans to list on the Nasdaq under the symbol VITA. Viventia Bio filed confidentially on September 17, 2015

 

Read more here.

Back

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.

Subscribe